Literature DB >> 22722755

The potential of using enzyme-linked immunospot to diagnose cephalosporin-induced maculopapular exanthems.

Boonthorn Tanvarasethee1, Supranee Buranapraditkun, Jettanong Klaewsongkram.   

Abstract

There is no reliable test to diagnose cephalosporin-induced maculopapular exanthems (MPE). This study aimed to evaluate the role of enzyme-linked immunospot assay in the diagnosis of cephalosporin-induced MPE compared with skin testing. A total of 25 patients with a history of cephalosporin-induced MPE were skin tested and the frequencies of cephalosporin-specific interferon-γ-, interleukin-5-, and interleukin-10-releasing cells/10(6) peripheral blood mononuclear cells were measured after stimulating with the culprit drug, compared with 20 non-allergic controls. Values greater than means+2 standard deviations of the values in non-allergic controls were considered diagnostic. The study showed that the combination of interferon-γ and interleukin-5 enzyme-linked immunospot assays was more sensitive than skin testing to diagnose cephalosporin allergy (40% vs. 8%, p = 0.008) and sensitivity increased to 57.1% when the test was performed within 2 years of the drug reaction. Enzyme-linked immunospot assay is a promising tool for confirming the diagnosis of cephalosporin-induced MPE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22722755     DOI: 10.2340/00015555-1386

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  14 in total

Review 1.  Antibiotic Allergy in Pediatrics.

Authors:  Allison Eaddy Norton; Katherine Konvinse; Elizabeth J Phillips; Ana Dioun Broyles
Journal:  Pediatrics       Date:  2018-05       Impact factor: 7.124

Review 2.  The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

Authors:  Jason A Trubiano; Cosby A Stone; M Lindsay Grayson; Karen Urbancic; Monica A Slavin; Karin A Thursky; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017-08-23

3.  The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions.

Authors:  Jason A Trubiano; Kaija Strautins; Alec J Redwood; Rebecca Pavlos; Katherine C Konvinse; Ar Kar Aung; Monica A Slavin; Karin A Thursky; M Lindsay Grayson; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017-10-31

4.  Hypersensitivity due to ceftriaxone mimicking measles in a child.

Authors:  Russelian Arulraj; Chandrasekaran Venkatesh; Nanda Chhavi; Palanisamy Soundararajan
Journal:  Indian J Pharmacol       Date:  2013 Sep-Oct       Impact factor: 1.200

Review 5.  Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity.

Authors:  Katherine C Konvinse; Elizabeth J Phillips; Katie D White; Jason A Trubiano
Journal:  Curr Opin Infect Dis       Date:  2016-12       Impact factor: 4.915

6.  Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?

Authors:  Rannakoe J Lehloenya; Jonny G Peter; Ana Copascu; Jason A Trubiano; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2020-10

Review 7.  Non-immediate Cutaneous Reactions to Beta-Lactams: Approach to Diagnosis.

Authors:  Antonino Romano; Rocco Luigi Valluzzi; Cristiano Caruso; Michela Maggioletti; Francesco Gaeta
Journal:  Curr Allergy Asthma Rep       Date:  2017-04       Impact factor: 4.919

Review 8.  Cellular in vitro diagnosis of adverse drug reactions.

Authors:  Christian Möbs; Wolfgang Pfützner
Journal:  Allergo J Int       Date:  2014-08-07

9.  A case of sulfasalazine-induced hypersensitivity syndrome confirmed by enzyme-linked immunospot assay.

Authors:  Parkpoom Phatharacharukul; Jettanong Klaewsongkram
Journal:  Allergy Asthma Immunol Res       Date:  2013-07-02       Impact factor: 5.764

Review 10.  How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?

Authors:  Josué da Costa Lima-Junior; Fernanda Nazaré Morgado; Fátima Conceição-Silva
Journal:  Cells       Date:  2017-09-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.